Patterns of associations of clinical features in neurofibromatosis 1 (NF1)

作者: Jacek Szudek , D Gareth Evans , Jan M Friedman , None

DOI: 10.1007/S00439-002-0871-7

关键词:

摘要: Neurofibromatosis 1 (NF1) is a common, fully penetrant autosomal dominant disease. The clinical course generally progressive but highly variable, and the pathogenesis poorly understood. We studied statistical associations among 13 of most common or important features in data from four separate sets NF1 patients: "developmental sample" 1,413 probands NNFF International Database, an independent "validation 1,384 same database, 511 affected relatives these probands, 441 patients population-based registry northwest England. developed logistic regressive models for each using developmental sample attempted to validate other three samples. Age gender were included as covariates all models. Models successfully validated ten analysed. results are consistent with grouping nine into sets: (1) cafe-au-lait spots, intertriginous freckling Lisch nodules; (2) cutaneous, subcutaneous plexiform neurofibromas; (3) macrocephaly, optic glioma neoplasms. In addition, three-way interactions neurofibromas indicate that first two groups not independent. Our studies show some individuals more likely than others develop certain Some appear share pathogenic mechanisms features.

参考文章(33)
S. M. Huson, D. F. Easton, M. A. Ponder, B. A. J. Ponder, An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. American Journal of Human Genetics. ,vol. 53, pp. 305- 313 ,(1993)
Michaela Livia Bajenaru, Jessica Donahoe, Teresa Corral, Karlyne M. Reilly, Sean Brophy, Angel Pellicer, David H. Gutmann, Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes. Glia. ,vol. 33, pp. 314- 323 ,(2001) , 10.1002/1098-1136(20010315)33:4<314::AID-GLIA1030>3.0.CO;2-Q
J E Allanson, M Upadhyaya, G H Watson, M Partington, A MacKenzie, D Lahey, H MacLeod, M Sarfarazi, W Broadhead, P S Harper, Watson syndrome: is it a subtype of type 1 neurofibromatosis? Journal of Medical Genetics. ,vol. 28, pp. 752- 756 ,(1991) , 10.1136/JMG.28.11.752
Stanley Lemeshow, David W. Hosmer, Applied Logistic Regression ,(1989)
Francis J. DiMario, Gale R. Ramsby, Joseph A. Burleson, Brain morphometric analysis in neurofibromatosis 1 JAMA Neurology. ,vol. 56, pp. 1343- 1346 ,(1999) , 10.1001/ARCHNEUR.56.11.1343
Sonja A. Rasmussen, Jennifer Overman, Susanne A.M. Thomson, Steven D. Colman, Corinne R. Abernathy, Rachael E. Trimpert, Rebecca Moose, Gurinder Virdi, Kyle Roux, Mislen Bauer, Amyn M. Rojiani, Bernard L. Maria, David Muir, Margaret R. Wallace, Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1. Genes, Chromosomes and Cancer. ,vol. 28, pp. 425- 431 ,(2000) , 10.1002/1098-2264(200008)28:4<425::AID-GCC8>3.0.CO;2-E
Darryl Carter, Atlas of Tumor Pathology: Tumors of the Peripheral Nervous System. The American Journal of Surgical Pathology. ,vol. 24, pp. 1311- 1312 ,(2000) , 10.1097/00000478-200009000-00021